It could be summarized that CKS1B was significantly positively linked to TMB in pancreatic cancer (R=0.49, P=1.4e-10) (Supplementary Figure 7D), which confirmed our hypothesis that CKS1B may exert anti-tumor immunity by influencing immune microenvironment. Here, CKS1B is linked to pancreatic neoplasm.